Concepedia

Author

Shreyaskumar Patel

The University of Texas MD Anderson Cancer CenterORCID

Also Known As

Elena Palassini, Kandarpkumar Patel, Patel, Shreyaskumar, Redmond, Kristin, S Patel, S R Patel, S. Patel, S. R. Patel, S.R Patel, S.R. Patel

452

Publications

25.8K

Citations

79

H-Index

83

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterSarcoma Oncology CenterMemorial Sloan Kettering Cancer CenterFox Chase Cancer CenterUniversity of Michigan
SP

About

Shreyaskumar Patel is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

52

7K

2

Health Sciences

10

10

739

3

Engineering

1

1

24

4

Cell Biology

1

1

47

5

Cellular Therapies

1

1

47

Shreyaskumar Patel

×

165

Publications

21.6K

Citations

73

H-Index

YearCitations

Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria

Haesun Choi, C Charnsangavej, Silvana C. Faria,

Journal of Clinical Oncology

2007

1.5K

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack,

The Lancet Oncology

2017

1.4K

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu,

The Lancet

2009

1.3K

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

George D. Demetri, Margaret von Mehren, Robin L. Jones,

Journal of Clinical Oncology

2015

809

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

Patrick Schöffski, Sant P. Chawla, Robert G. Maki,

The Lancet

2016

753

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel,

Journal of Clinical Oncology

2007

719

Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy

Gunar K. Zagars, Matthew T. Ballo, Peter W. T. Pisters,

Cancer

2003

666

We Should Desist Using RECIST, at Least in GIST

Robert S. Benjamin, Haesun Choi, Homer A. Macapinlac,

Journal of Clinical Oncology

2007

551

Spinal Instability Neoplastic Score: An Analysis of Reliability and Validity From the Spine Oncology Study Group

Daryl R. Fourney, Evan Frangou, Timothy C. Ryken,

Journal of Clinical Oncology

2011

522

Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators

Montserrat Ayala‐Ramirez, Lei Feng, Marcella M. Johnson,

The Journal of Clinical Endocrinology & Metabolism

2010

419

Page 1